Home

Results 31 - 40 of 451,583 for medical products. Search took 0.475 seconds.  
Sort by date/Sort by relevance
The glass vials and label are different from genuine COVID-19 Vaccine BNT162b2 vials.   Table 1: Products subject of WHO Medical Product Alert N°2/2021 Advice to regulatory authorities and the public WHO requests increased vigilance within the supply chains of countries and regions likely to be affected by these falsified products. Increased vigilance should include hospitals, clinics, health centers, wholesalers, distributors, pharmacies, and any other suppliers of medical products. All medical products must be obtained from authorized/licensed suppliers. (...) If you are in possession of the above products, please do not use them. If you have used these products, or you suffered an adverse reaction/event having used these products, you are advised to seek immediate medical advice from a qualified healthcare professional and to report the incident to the National Regulatory Authorities/National Pharmacovigilance Centre.
Language:English
Score: 845339 - https://www.who.int/news/item/...fied-covid-19-vaccine-bnt162b2
Data Source: un
Medical Product Alert N°6/2021: Falsified Pfizer-BioNTech COVID-19 Vaccine Global Regions WHO Regional websites Africa Americas South-East Asia Europe Eastern Mediterranean Western Pacific When autocomplete results are available use up and down arrows to review and enter to select. (...) Increased vigilance should include hospitals, clinics, health centres, wholesalers, distributors, pharmacies, and any other suppliers of medical products. All medical products must be obtained from authorized/licensed suppliers. (...) If you are in possession of the above-falsified products, please do not use them. If you have used these products, or you suffered an adverse reaction/event having used these products, you are advised to seek immediate medical advice from a qualified healthcare professional and to report the incident to the National Regulatory Authorities / National Pharmacovigilance Centre.
Language:English
Score: 844821.8 - https://www.who.int/news/item/...izer-biontech-covid-19-vaccine
Data Source: un
27 April 2020 Page: 1/10 Original: English 1 THE TREATMENT OF MEDICAL PRODUCTS IN REGIONAL TRADE AGREEMENTS INFORMATION NOTE1 Key points • The share of exports by the world's top 10 exporters of medical products to their regional trade agreement (RTA) partners ranges from between 27 per cent for China to almost 77 per cent for the Netherlands. (...) We follow the methodology identified by the WTO Secretariat. Medical products are defined as six- digit subheadings in the Harmonized System classified under four categories: (i) medical equipment; (ii) medical supplies; (iii) medicines; and (iv) PP products, including hand sanitizers and face masks.2 2 RTA TRADE AND TARIFF PREFERENCES The top 10 exporters of medical products, which account for almost 75 per cent of global exports of these products, are all parties to RTAs. (...) The overall rate (both MFN and preferential) is considerably higher for PP products and medical supplies than for the other two categories of products.
Language:English
Score: 844729.1 - https://www.wto.org/english/tr.../medical_products_report_e.pdf
Data Source: un
Promoting local production and supply of quality-assured medical products to improve access in the WHO South-East Asia region Global Regions WHO Regional websites Africa Americas South-East Asia Europe Eastern Mediterranean Western Pacific When autocomplete results are available use up and down arrows to review and enter to select. (...) The goal of the training workshop was to strengthen the capacity of local manufacturers in the WHO South-East Asia Region in the sustainable production of quality-assured medical products. More than 90 participants attended the training workshop. (...) Highlights of the training workshop were as follows: Sustainable local production of quality medical products requires a holistic and coordinated strategy Compliance with international GxP standards and norms is key to the production of high quality medical products An enabling policy, business and regulatory environment is critical for sustainable local production of quality medical products Technology transfer can facilitate local production of vaccines and other difficult to produce medical products in developing countries Manufacturers from the region appreciated the training workshop with participants calling for country-specific training programmes as the South East Asia region has members with different levels of local production.
Language:English
Score: 844570.5 - https://www.who.int/news/item/...the-who-south-east-asia-region
Data Source: un
A priority in local regulatory development should be the establishment of vendor and product registrations. Education and training of users, and the continued assessment of medical devices in use is as important as product control. (...) Since most developing countries import medical devices, priority should be given to vendor and product registrations, user training and post-market surveillance of devices (correct use, problem alerts and recalls). Although in-country pre-market product control requires resources and expertise, governments could benefit from the work of major medical device manufacturing countries to assure regulatory compliance.
Language:English
Score: 843795.9 - https://www.who.int/medical_de...lications/en/AM_Devices_EN.pdf
Data Source: un
Medical Product Alert N°1/2021: Falsified Vitamin A Global Regions WHO Regional websites Africa Americas South-East Asia Europe Eastern Mediterranean Western Pacific When autocomplete results are available use up and down arrows to review and enter to select. (...) Table 1: Products subject of WHO Medical Product Alert N°1/2021 Genuine VITAMIN A (RETINOL), batch UI4004, was manufactured by Accucaps Industries Limited in September 2009, with an expiry date of September 2012. (...) All medical products must be obtained from authorized/licensed suppliers.
Language:English
Score: 843673.7 - https://www.who.int/news/item/...t-n-1-2021-falsified-vitamin-a
Data Source: un
Select language Select language English South-East Asia India Home Health topics Our work News Emergencies About us Home / News / Detail / Union Health Minister inaugurates ‘2019 World Conference on Access to Medical Products’ Union Health Minister inaugurates ‘2019 World Conference on Access to Medical Products’ 19 November 2019 Highlights 19 November 2019, New Delhi: The three-day 2019 World Conference on ‘Access to Medical Products: Achieving the SDGs 2030’ was inaugurated by Dr Harsh Vardhan, Union Minister of Health & Family Welfare and Science & Technology and Earth Sciences, Government of India in New Delhi today. (...) The conference will spur innovative thinking around issues surrounding provisioning of affordable, quality medical products as part of public health care delivery systems,” Dr Harsh Vardhan further added. (...) The Honourable Ministers also reiterated their commitment for access to medical products as envisioned in the 2018 Delhi Declaration.
Language:English
Score: 841655.3 - https://www.who.int/india/news...-on-access-to-medical-products
Data Source: un
Dr Soumya Swaminathan, Chief Scientist, World Health Organisation in her video address reiterated the need for regulatory systems strengthening, including participating in regulatory networks such as South East Asia Regulatory Network, for promoting access to medical products. “WHO is committed to providing access to safe and affordable medical products to all,” she affirmed. The conference provided a valuable platform for sharing experiences and advancing increased access to medical products globally. The key dignitaries unanimously agreed to the fact that this conference will spur innovative thinking around issues surrounding the provisioning of affordable and quality medical products as part of public health care delivery systems. (...) The main sessions covered on Day 2 were: Leveraging Regulatory Networks for Access to Quality, Safe and Affordable Medical Products Including Digital Tools for Strengthening Regulatory Systems; Smart Safety Surveillance for Strengthening Pharmaco-vigilance Systems- Progress Updates and Next Steps; Moving Towards Smarter Clinical Trials– Changing the Paradigm in the Context of Global and Multi Regional Clinical Trials; Medical Technology Pathways for Innovative Medical Devices; Medical Products for End game for HIV/AIDS, Tuberculosis, Malaria; Global Partnerships for Drug Discovery, Innovation and Technology Development: Scaling up Adaptive Technology Solutions for Medical Products and Re-purposing of Medicines for Reduced Approval Timeframe, Decreased Costs and Making Use of Existing Data.
Language:English
Score: 841443.8 - https://www.who.int/india/day-2-update
Data Source: un
WHO | Local production & technology transfer for access to quality medical products Global Regions WHO Regional websites Africa Americas South-East Asia Europe Eastern Mediterranean Western Pacific When autocomplete results are available use up and down arrows to review and enter to select. (...) Local production Technology transfer Low- and middle-income countries (LMICs) are becoming increasingly interested in developing the local production of quality-assured medical products. LMICs view local production as a strategy to improve access to quality medical products, achieve universal health coverage, strengthen health security and reach the health-related targets and broader development goals of the SDGs.
Language:English
Score: 840250.2 - https://www.who.int/phi/implementation/tech_transfer/en/
Data Source: un
Chart 1: Year-on-year trade growth in medical goods, by product group, 2020 S2 and 2021 S1 Source: WTO Secretariat. (...) The growth and share of the four main groups of medical products varied during the last two years, as the pandemic unfolded. (...) As a share of all medical products, medicine has consistently accounted for more than half of the value of trade in medical products (see Chart 2).
Language:English
Score: 839785.1 - https://www.wto.org/english/tr...dical_goods_update_dec21_e.pdf
Data Source: un